Dr. Gerard Anderson, a professor in the department of health policy and management at the Johns Hopkins Bloomberg School of Public Health, has received a 2.5-year grant of $4.3 million from Arnold Ventures. Dr. Anderson and his team will develop proposals to lower spending on pharmaceutical drugs while still supporting drug innovation, research and development. Dr. Anderson also directs the Center for Hospital Finance and Management at the Bloomberg School.
Spending on pharmaceuticals is increasing at rapid rates and prescription drugs are becoming less affordable for many Americans. Policymakers, members of Congress and private insurers are examining approaches to control drug spending without adversely impacting drug innovation. The study will examine factors associated with the increase in drug spending for generic, branded and specialty drugs in attempts to develop policies to lower the launch price, slow the rate of price increases and modify the choices patients have when choosing drug plans.
Dr. Anderson and his team have already created large databases that examine trends in spending and utilization for prescription drugs in both the public and private sectors. The team will use these data sets to assist policymakers in understanding the cost and clinical implications of various policy alternatives. The team expects to present the findings to members of Congress, Congressional staff, senior members of the Administration, state officials and private insurers.Tags: Friday Letter Submission, Publish on July 26